CoChat

Magnesium sulphate versus lytic cocktail for eclampsia

Open access
Duley, Lelia, Gülmezoglu, A Metin, Chou, Doris · 2010 · Cochrane Database of Systematic Reviews
Cited by 133

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Eclampsia, the occurrence of a seizure in association with pre-eclampsia, is a rare but serious complication of pregnancy. A number of different anticonvulsants have been used to control eclamptic fits and to prevent further seizures. OBJECTIVES: The objective of this review was to assess the effects of magnesium sulphate compared with lytic cocktail (usually chlorpromazine, promethazine and pethidine) when used for the care of women with eclampsia. Magnesium sulphate is compared with diazepam and with phenytoin in other Cochrane reviews. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (July 2010) and the Cochrane Central Register of Trials (The Cochrane Library 2010, Issue 2). SELECTION CRITERIA: Randomised trials comparing magnesium sulphate (intravenous or intramuscular administration) with lytic cocktail for women with a clinical diagnosis of eclampsia. DATA COLLECTION AND ANALYSIS: Two review authors (L Duley and D Chou) assessed trial quality and extracted data. MAIN RESULTS: We included three small trials (total 397 women) of average quality in the review. Magnesium sulphate was associated with fewer maternal deaths (risk ratio (RR) 0.14, 95% confidence interval (CI) 0.03 to 0.59; 3 trials, 397 women) and was better at preventing further seizures (RR 0.06, 95% CI 0.03 to 0.12; 3 trials, 397 women) than lytic cocktail. Magnesium sulphate was also associated with less respiratory depression (RR 0.12, 95% CI 0.02 to 0.91; 2 trials, 198 women), less coma (RR 0.04, 95% CI 0.00 to 0.74; 1 trial, 108 women), and less pneumonia (RR 0.20, 95% CI 0.06 to 0.67; 2 trials, 307 women). There was no clear difference in the RR for any death of the baby (RR 0.35, 95% CI 0.05 to 2.38, random effects; 2 trials, 177 babies). AUTHORS' CONCLUSIONS: Magnesium sulphate, rather than lytic cocktail, for women with eclampsia reduces the RR of maternal death, of further seizures and of serious maternal morbidity (respiratory depression, coma, pneumonia). Magnesium sulphate is the anticonvulsant of choice for women with eclampsia; the use of lytic cocktail should be abandoned.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd002960.pub2

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 71

  1. Nagar, 1988, Reassessment of therapy of eclampsia: comparison of mortality and morbidity of mother and fetus with parenteral magnesium sulphate and lytic cocktail therapy, Journal of Obstetrics and Gynaecology of India, 38, 250
  2. Bhalla, 1994, A safer and more effective treatment regimen for Eclampsia, Australian and New Zealand Journal of Obstetrics and Gynaecology, 34, 144, 10.1111/j.1479-828X.1994.tb02677.x · doi:10.1111/j.1479-828x.1994.tb02677.x
  3. Jacob S Gopalakrishnan K Lalitha K Standardised clinical trial of magnesium sulphate regime in comparison with M.K.K. Menon's lytic cocktail regime in the management of eclampsia Proceedings of the 27th British Congress of Obstetrics and Gynaecology; 1995 4-7 July; Dublin, Ireland 1995 303
  4. Chatterjee, 1997, Comparative study of different anticonvulsants in eclampsia, Journal of Obstetrics and Gynaecology Research, 23, 289, 10.1111/j.1447-0756.1997.tb00847.x · doi:10.1111/j.1447-0756.1997.tb00847.x
  5. Samal, 2001, Management of eclampsia with magnesium sulphate and nifedipine, Journal of Obstetrics and Gynecology of India, 51, 71
  6. Hangarga, 2001, A comparative study of phenytoin sodium with magnesium sulphate and Menon's regime in the treatment of eclampsia, Journal of Obstetrics and Gynecology of India, 51, 68
  7. Abalos, 2007, Antihypertensive drug therapy for mild to moderate hypertension during pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002252.pub2 · DOI · Paper page
  8. Ananth, 1995, Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1988 to 1991, Acta Obstetricia et Gynecologica Scandinavica, 74, 788, 10.3109/00016349509021198 · DOI · Paper page
  9. Andersgaard, 2006, Eclampsia in Scandinavia: incidence, substandard care, and potentially preventable cases, Acta Obstetricia et Gynecologica Scandinavica, 85, 929, 10.1080/00016340600607149 · doi:10.1080/00016340600607149
  10. Baldessarini, 2006, Pharmacotherapy of psychosis and mania
  11. Belfort, 1992, Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study, American Journal of Obstetrics and Gynecology, 167, 661, 10.1016/S0002-9378(11)91567-1 · DOI · Paper page
  12. Churchill, 2002, Interventionist versus expectant care for severe pre-eclampsia before term, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003106 · DOI · Paper page
  13. The Eclampsia Trial Collaborative Group, 1995, Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial, Lancet, 345, 1455, 10.1016/S0140-6736(95)91034-4 · DOI · Paper page
  14. Dinsdale, 1988, Does magnesium sulfate treat eclamptic seizures? Yes, Archives of Neurology, 45, 1360, 10.1001/archneur.1988.00520360078016 · doi:10.1001/archneur.1988.00520360078016
  15. Douglas, 1994, Eclampsia in the United Kingdom, BMJ, 309, 1395, 10.1136/bmj.309.6966.1395 · DOI · Paper page
  16. Duley, 1992, Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean, British Journal of Obstetrics and Gynaecology, 99, 547, 10.1111/j.1471-0528.1992.tb13818.x · DOI · Paper page
  17. Duley, 1996, The Collaborative Eclampsia Trial: which anticonvulsant for women with eclampsia [thesis]
  18. Duley, 1999, Plasma volume expansion for treatment of pre-eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001805 · DOI
  19. Duley, 2003, Magnesium sulphate and other anticonvulsants for women with pre-eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000025 · DOI · Paper page
  20. Duley, 2003, Magnesium sulphate versus phenytoin for eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000128 · DOI
  21. Duley, 2003, Magnesium sulphate versus diazepam for eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000127 · DOI
  22. Duley, 2005, Altered dietary salt for preventing pre-eclampsia, and its complications, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005548 · DOI · Paper page
  23. Duley, 2006, Drugs for treatment of very high blood pressure during pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001449.pub2 · DOI · Paper page
  24. Duley, 2007, Antiplatelet agents for preventing pre-eclampsia and its complications, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD004659.pub2 · DOI · Paper page
  25. Duley, 2008, Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007388 · doi:10.1002/14651858.cd007388
  26. Duley, 2009, Interventions for treating pre-eclampsia and its consequences: generic protocol, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007756 · DOI
  27. Eastman, 1945, The management of pre-eclampsia, Canadian Medical Association Journal, 52, 562
  28. Euser, 2009, Magnesium sulfate for the treatment of eclampsia: a brief review, Stroke, 40, 1169, 10.1161/STROKEAHA.108.527788 · DOI · Paper page
  29. Frias, 2003, Post Magpie: how should we be managing severe preeclampsia?, Current Opinion in Obstetrics and Gynecology, 15, 489, 10.1097/00001703-200312000-00006 · DOI
  30. Goldman, 1988, Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure, New England Journal of Medicine, 319, 1224, 10.1056/NEJM198811033191813 · doi:10.1056/nejm198811033191813
  31. Gutstein, 2006, Opioid analgesics
  32. Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org · DOI · Paper page
  33. Hofmeyr, 2007, Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary, BJOG: an international journal of obstetrics and gynaecology, 114, 933, 10.1111/j.1471-0528.2007.01389.x · DOI · Paper page
  34. Igberase, 2006, Eclampsia: ten-years of experience in a rural tertiary hospital in the Niger delta, Nigeria, Journal of Obstetrics and Gynaecology, 26, 414, 10.1080/01443610600720113 · DOI
  35. Katz, 2000, Preeclampsia into eclampsia: toward a new paradigm, American Journal of Obstetrics and Gynecology, 182, 1389, 10.1067/mob.2000.106178 · doi:10.1067/mob.2000.106178
  36. Knight, 2007, Eclampsia in the United Kingdom 2005, BJOG: an international journal of obstetrics and gynaecology, 114, 1072, 10.1111/j.1471-0528.2007.01423.x · DOI · Paper page
  37. Kullberg, 2002, Eclampsia in Sweden, Hypertension in Pregnancy, 21, 13, 10.1081/PRG-120002906 · DOI
  38. Langer, 2008, Reducing eclampsia-related deaths--a call to action, Lancet, 371, 705, 10.1016/S0140-6736(08)60321-9 · DOI
  39. Lewis, 2007, The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving mothers’ lives: reviewing maternal deaths to make motherhood safer - 2003-2005. The seventh report on confidential enquiries into maternal deaths in the United Kingdom
  40. Lumbiganon, 2007, Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be, Bulletin of the World Health Organization, 85, 763, 10.2471/BLT.06.037911 · DOI
  41. Altman, 2002, Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial, Lancet, 359, 1877, 10.1016/S0140-6736(02)08778-0 · DOI · Paper page
  42. Mahomed, 2007, Zinc supplementation for improving pregnancy and infant outcome, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000230.pub3 · DOI
  43. Makrides, 2001, Magnesium supplementation in pregnancy, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD000937 · DOI
  44. Makrides, 2006, Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003402.pub2 · DOI · Paper page
  45. Meads, 2008, Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling, Health Technology Assessment, 12, iii-iv, 1-270, 10.3310/hta12060 · DOI · Paper page
  46. Meher, 2005, Interventions for preventing pre-eclampsia and its consequences: generic protocol, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005301 · DOI · Paper page
  47. Meher, 2006, Exercise or other physical activity for preventing pre-eclampsia and its complications, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD005942 · DOI · Paper page
  48. Meher, 2007, Nitric oxide for preventing pre-eclampsia and its complications, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD006490 · DOI
  49. Menon, 1961, The evolution of the treatment of eclampsia, Journal of Obstetrics and Gynaecology of the British Commonwealth, 68, 417, 10.1111/j.1471-0528.1961.tb02747.x · doi:10.1111/j.1471-0528.1961.tb02747.x
  50. Milne, 2005, The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community, BMJ, 330, 576, 10.1136/bmj.330.7491.576 · DOI · Paper page
  51. Chang, 2003, Pregnancy-related mortality surveillance-United States, 1991-1999, MMWR. Surveillance Summaries, 52, 1
  52. Neilson, 1995, Magnesium sulphate: the drug of choice in eclampsia, BMJ (Clinical research ed.), 311, 702
  53. National Institute for Health and Clinical Excellence, 2008, Antenatal care
  54. Onuh, 2004, Maternal and fetal outcome in eclamptic patients in Benin City, Nigeria, Journal of Obstetrics and Gynaecology, 24, 765, 10.1080/01443610400009451 · DOI
  55. Pritchard, 1955, The use of the magnesium ion in the management of eclamptogenic toxemias, Surgery, Gynecology and Obstetrics, 100, 131
  56. Tuffnell, 2006, The management of severe pre-eclampsia/eclampsia. Greentop Guidelines (10A)
  57. Redman, 1984, Hypertension in pregnancy, 141
  58. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008
  59. Roberts, 2002, Preventing and treating eclamptic seizures, BMJ (Clinical research ed.), 325, 609
  60. Roberts, 2005, Hypertensive disorders in pregnancy: a population-based study, Medical Journal of Australia, 182, 332, 10.5694/j.1326-5377.2005.tb06730.x · DOI · Paper page
  61. Robson, 1996, Magnesium sulphate: the time of reckoning, British Journal of Obstetrics and Gynaecology, 103, 99, 10.1111/j.1471-0528.1996.tb09656.x · DOI
  62. Rumbold, 2008, Antioxidants for preventing pre-eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD004227.pub3 · DOI · Paper page
  63. Sadeh, 1989, Action of magnesium sulfate in the treatment of preeclampsia-eclampsia, Stroke, 20, 1273, 10.1161/01.STR.20.9.1273 · doi:10.1161/01.str.20.9.1273
  64. Sheth, 2002, Magnesium for preventing and treating eclampsia: time for international action, Lancet, 359, 1872, 10.1016/S0140-6736(02)08783-4 · DOI
  65. Sibai, 2005, Diagnosis, prevention, and management of eclampsia, Obstetrics & Gynecology, 105, 402, 10.1097/01.AOG.0000152351.13671.99 · DOI · Paper page
  66. Skidgel Randal, 2006, Histamine, bradykinin, and their antagonists
  67. Villar, 2003, Eclampsia and pre-eclampsia: a health problem for 2000 years, 189
  68. World Health Organization, 1988, Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy, American Journal of Obstetrics and Gynecology, 158, 80
  69. World Health Organization, 2007, Managaing complications in pregnancy and childbirth: a guide for midwives and doctors
  70. Zuspan, 1978, Problems encountered in the treatment of pregnancy-induced hypertension. A point of view, American Journal of Obstetrics and Gynecology, 131, 591, 10.1016/0002-9378(78)90816-5 · DOI
  71. Duley, 2000, Magnesium sulphate versus lytic cocktail for eclampsia, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002960 · DOI · Paper page

Cited by

See all 133

Metadata

Authors
Duley, L., Gülmezoglu, A. M., & Chou, D.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2010-09-08
Volume
2011
Issue
4
Pages
CD002960-CD002960
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W1876623928
Cited by
133
References
4
FWCI
13.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.